Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Terminated × Triiodothyronine × Clear all

Phase

Phase NA 2 Phase 2 1 Phase 1 1

Status

Completed 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 166 Docetaxel 153 Bevacizumab 153 Carboplatin 145 Gemcitabine 144 Cisplatin 142 pembrolizumab 141 Radiotherapy 134 Paclitaxel 130 Capecitabine 121 Rituximab 115 Oxaliplatin 103 Fluorouracil 102 Nivolumab 90 Irinotecan 85 Doxorubicin 85 Leucovorin 81 Dexamethasone 81 Pemetrexed 80 fludarabine 74 fludarabine phosphate 72 Bortezomib 68 Etoposide 66 Erlotinib Hydrochloride 66 Cetuximab 64 Methotrexate 58 Trastuzumab 56 Cytarabine 54 Lenalidomide 49 Everolimus 49

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03787303 2022-05-13

B-TREUH

Aultman Health Foundation

Phase 2 Terminated

7 enrolled 14 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡